Article

New Research Identifies Molecule that Produces Allergic Response

A new study from the MD Anderson Cancer Center at the University of Texas has identified a molecule that "specifically directs immune cells to develop the capability to produce an allergic response."

A new study from the MD Anderson Cancer Center at the University of Texas has identified a molecule that “specifically directs immune cells to develop the capability to produce an allergic response."

Lead researcher Yong-Jun Liu, MD, PhD, and the rest of the research team found that when the signaling molecule thymic stromal lymphopoietin (TSLP) bound to dendritic cells, a “distinct” set of signaling pathways were activated. This activation caused the dendritic cells to produce messenger molecules that acted on the T cells, causing them to develop into Th2 cells. According to the researchers, this process identified in the study pinpoints “TSLP as a switch that causes the development of the allergic response in people and suggests that this molecule may be a potential therapeutic target to treat and prevent allergic diseases.”

Although it was previously known that dendritic cells could come into contact with T cells and produce either helper 1 (Th1) or helper 2 (Th2) cells, according to the researchers, it was not clear how the dendritic cells led the T cells to become Th2 cells. This new study, according to the researchers, identifies TSLP as the mechanism for that reaction.

The study was also published in Science Signaling.

Related Videos
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD
Impact of the Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD
James Palmer, MD | Credit: Penn Medicine
Robert Wood, MD | Credit: LinkedIn
Robert Wood, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.